Trevi Therapeutics (TRVI) Institutional Ownership $6.25 -0.26 (-3.99%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$6.25 0.00 (0.00%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Trevi Therapeutics (NASDAQ:TRVI)CurrentInstitutional OwnershipPercentage95.76%Number ofInstitutional Buyers(last 12 months)72TotalInstitutional Inflows(last 12 months)$172.11MNumber ofInstitutional Sellers(last 12 months)21TotalInstitutional Outflows(last 12 months)$43.52M Get TRVI Insider Trade Alerts Want to know when executives and insiders are buying or selling Trevi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRVI Institutional Buying and Selling by Quarter Trevi Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/29/2025 Rhumbline Advisers90,482$569K0.0%+13.3%0.091% 5/28/2025 Strs Ohio8,200$52K0.0%N/A0.008% 5/19/2025 Acorn Capital Advisors LLC2,144,844$13.49M8.8%+7.2%2.147% 5/16/2025 Woodline Partners LP2,057,812$12.94M0.1%-35.9%2.060% 5/16/2025 Exome Asset Management LLC163,738$1.03M0.9%N/A0.164% 5/16/2025 Octagon Capital Advisors LP3,322,000$20.90M2.2%N/A3.326% 5/16/2025 Fred Alger Management LLC76,699$482K0.0%N/A0.077% 5/16/2025 Goldman Sachs Group Inc.211,873$1.33M0.0%-10.3%0.212% 5/16/2025 Polar Asset Management Partners Inc.64,050$403K0.0%N/A0.064% 5/16/2025 Millennium Management LLC823,249$5.18M0.0%+356.3%0.824% Get the Latest News and Ratings for TRVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.44,143$278K0.0%+31.0%0.044% 5/16/2025 AQR Capital Management LLC27,720$174K0.0%+20.4%0.028% 5/16/2025 Ally Bridge Group NY LLC686,219$4.32M3.9%-12.2%0.687% 5/16/2025 Adage Capital Partners GP L.L.C.440,000$2.77M0.0%-82.4%0.440% 5/15/2025 MPM Bioimpact LLC3,428,366$21.56M3.7%+10.8%3.432% 5/15/2025 Frazier Life Sciences Management L.P.10,259,409$64.53M2.9%-3.8%10.270% 5/15/2025 Braidwell LP72,083$453K0.0%N/A0.072% 5/15/2025 Cubist Systematic Strategies LLC206,962$1.30M0.0%+131.7%0.207% 5/15/2025 Armistice Capital LLC2,988,000$18.80M0.3%N/A2.991% 5/15/2025 MAI Capital Management1,385,050$8.71M0.1%+2.1%1.387% 5/15/2025 Panagora Asset Management Inc.339,904$2.14M0.0%+182.5%0.340% 5/15/2025 Siren L.L.C.2,863,793$18.01M1.0%-1.5%2.867% 5/14/2025 Affinity Asset Advisors LLC1,250,000$7.86M0.8%N/A1.251% 5/14/2025 WealthTrust Axiom LLC63,500$399K0.1%-3.1%0.064% 5/14/2025 Corebridge Financial Inc.36,503$230K0.0%+21.3%0.037% 5/14/2025 MetLife Investment Management LLC44,656$281K0.0%+15.1%0.045% 5/14/2025 Jump Financial LLC160,815$1.01M0.0%+644.9%0.161% 5/14/2025 Hsbc Holdings PLC27,748$173K0.0%-38.0%0.028% 5/14/2025 Wellington Management Group LLP127,452$802K0.0%N/A0.128% 5/13/2025 Raymond James Financial Inc.509,379$3.20M0.0%+4,144.8%0.510% 5/13/2025 American Century Companies Inc.79,796$502K0.0%+2.1%0.080% 5/13/2025 Tejara Capital Ltd179,516$1.13M0.4%+16.8%0.180% 5/13/2025 Persistent Asset Partners Ltd41,404$260K0.2%N/A0.041% 5/13/2025 Informed Momentum Co LLC550,919$3.47M0.6%N/A0.552% 5/12/2025 Nuveen LLC273,620$1.72M0.0%N/A0.274% 5/12/2025 Invesco Ltd.852,985$5.37M0.0%+3,511.1%0.854% 5/9/2025 Deutsche Bank AG37,626$237K0.0%+28.7%0.038% 5/9/2025 Charles Schwab Investment Management Inc.207,518$1.31M0.0%+19.9%0.208% 5/9/2025 Vanguard Group Inc.3,838,032$24.14M0.0%+9.4%3.842% 5/9/2025 BIT Capital GmbH41,987$264K0.0%N/A0.042% Banks aren’t ready for this altcoin—are you? (Ad)While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.Click here to access the full report now.5/8/2025 XTX Topco Ltd10,380$65K0.0%-84.6%0.010% 4/30/2025 China Universal Asset Management Co. Ltd.17,925$113K0.0%+10.0%0.019% 4/29/2025 Bank of New York Mellon Corp166,076$1.05M0.0%+18.4%0.172% 4/28/2025 Vontobel Holding Ltd.31,359$197K0.0%N/A0.032% 4/24/2025 Diversified Trust Co15,002$94K0.0%N/A0.016% 4/23/2025 Oppenheimer & Co. Inc.100,437$632K0.0%+23.4%0.104% 4/8/2025 Rhumbline Advisers90,482$569K0.0%+13.3%0.094% 2/18/2025 Frazier Life Sciences Management L.P.10,664,774$43.94M1.8%+44.5%13.874% 2/17/2025 VR Adviser LLC1,266,457$5.22M0.4%-63.0%1.648% 2/17/2025 Woodline Partners LP3,212,597$13.24M0.1%+429.9%4.179% 2/17/2025 Squarepoint Ops LLC14,059$58K0.0%N/A0.018% 2/17/2025 Two Sigma Advisers LP15,900$66K0.0%N/A0.021% 2/17/2025 Two Sigma Investments LP135,807$560K0.0%N/A0.177% 2/17/2025 Point72 Asset Management L.P.4,150,237$17.10M0.0%N/A5.399% 2/17/2025 ProShare Advisors LLC20,685$85K0.0%+86.4%0.027% 2/17/2025 MPM Bioimpact LLC3,094,896$12.75M1.8%+101.2%4.026% 2/17/2025 Millennium Management LLC180,419$743K0.0%+774.9%0.235% 2/17/2025 Cubist Systematic Strategies LLC89,309$368K0.0%N/A0.116% 2/17/2025 Bridgeway Capital Management LLC177,481$731K0.0%-4.3%0.231% 2/17/2025 Cantor Fitzgerald L. P.20,000$82K0.0%N/A0.026% 2/17/2025 BNP Paribas Financial Markets7,686$32K0.0%-35.6%0.010% 2/17/2025 Ameriprise Financial Inc.96,784$399K0.0%+187.0%0.126% 2/17/2025 Algert Global LLC14,779$61K0.0%-39.9%0.019% 2/17/2025 Ally Bridge Group NY LLC781,489$3.22M2.7%-40.9%1.017% 2/17/2025 Acorn Capital Advisors LLC2,001,048$8.24M4.5%N/A2.603% 2/17/2025 Acuta Capital Partners LLC771,958$3.18M3.2%+165.7%1.004% 2/14/2025 Northern Trust Corp482,815$1.99M0.0%+11.3%0.628% 2/14/2025 Boothbay Fund Management LLC93,859$387K0.0%N/A0.122% 2/14/2025 Adage Capital Partners GP L.L.C.2,500,000$10.30M0.0%N/A3.252% 2/14/2025 Price T Rowe Associates Inc. MD25,166$104K0.0%+32.1%0.033% 2/14/2025 Silverarc Capital Management LLC734,234$3.03M0.7%+52.1%0.955% 2/14/2025 Vivo Capital LLC3,487,903$14.37M1.6%+116.3%4.537% 2/14/2025 MetLife Investment Management LLC38,785$160K0.0%+104.9%0.050% 2/14/2025 Dimensional Fund Advisors LP134,353$553K0.0%+86.1%0.175% 2/13/2025 Marshall Wace LLP42,921$177K0.0%-47.1%0.056% 2/13/2025 Jump Financial LLC21,589$89K0.0%N/A0.028% 2/13/2025 Walleye Capital LLC33,097$136K0.0%N/A0.043% 2/13/2025 XTX Topco Ltd67,201$277K0.0%N/A0.087% 2/13/2025 Barclays PLC156,267$643K0.0%+64.1%0.203% 2/13/2025 Summit Investment Advisors Inc.6,332$26K0.0%+84.2%0.008% 2/13/2025 Raymond James Financial Inc.12,000$49K0.0%N/A0.016% 2/13/2025 Renaissance Technologies LLC100,400$414K0.0%+42.0%0.131% 2/13/2025 Invesco Ltd.23,621$97K0.0%+21.2%0.031% 2/13/2025 Wells Fargo & Company MN33,050$136K0.0%+40.7%0.043% 2/12/2025 Landscape Capital Management L.L.C.52,085$215K0.0%-87.7%0.068% 2/12/2025 Geode Capital Management LLC1,299,322$5.35M0.0%+2.8%1.690% 2/12/2025 JPMorgan Chase & Co.221,664$913K0.0%+120.5%0.288% 2/11/2025 American Century Companies Inc.78,143$322K0.0%+44.7%0.102% 2/11/2025 Rosalind Advisors Inc.1,062,500$4.38M2.2%+41.7%1.382% 2/10/2025 Tejara Capital Ltd153,739$633K0.4%-36.4%0.200% Gold is soaring. Here’s how to get paid from it (Ad)Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.Click here to discover the income ETF behind it all.2/6/2025 Raymond James Financial Inc.12,000$49K0.0%N/A0.016% 2/6/2025 Charles Schwab Investment Management Inc.173,063$713K0.0%+14.7%0.225% 2/4/2025 Bank of New York Mellon Corp140,219$578K0.0%+2.1%0.182% 1/24/2025 China Universal Asset Management Co. Ltd.16,298$67K0.0%N/A0.021% 1/17/2025 SG Americas Securities LLC26,792$110K0.0%+14.5%0.035% 12/26/2024 JPMorgan Chase & Co.100,517$336K0.0%+220.6%0.131% 11/19/2024 Barclays PLC95,232$319K0.0%+180.8%0.124% 11/16/2024 Geode Capital Management LLC1,264,166$4.22M0.0%+10.2%1.645% 11/15/2024 Barclays PLC95,232$319K0.0%+180.8%0.124% 11/15/2024 Jane Street Group LLC32,929$110K0.0%-50.4%0.043% (Data available from 1/1/2016 forward) TRVI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRVI shares? During the previous two years, 88 institutional investors and hedge funds held shares of Trevi Therapeutics. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($64.53M), Vanguard Group Inc. ($24.14M), MPM Bioimpact LLC ($21.56M), Octagon Capital Advisors LP ($20.90M), Armistice Capital LLC ($18.80M), Siren L.L.C. ($18.01M), and Point72 Asset Management L.P. ($17.10M).Learn more on TRVI's institutional investors. What percentage of Trevi Therapeutics stock is owned by institutional investors? 95.76% of Trevi Therapeutics stock is owned by institutional investors. Learn more on TRVI's institutional investor holdings. Which institutional investors have been buying Trevi Therapeutics stock? Of the 77 institutional investors that purchased Trevi Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Point72 Asset Management L.P. ($4.15M), Frazier Life Sciences Management L.P. ($3.78M), Octagon Capital Advisors LP ($3.32M), Armistice Capital LLC ($2.99M), Woodline Partners LP ($2.61M), Adage Capital Partners GP L.L.C. ($2.50M), and Acorn Capital Advisors LLC ($2.14M). How much institutional buying is happening at Trevi Therapeutics? Institutional investors have bought a total of 38,501,903 shares in the last 24 months. This purchase volume represents approximately $176.94M in transactions. Which Trevi Therapeutics major shareholders have been selling company stock? Of the 25 institutional investors that sold Trevi Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: VR Adviser LLC ($2.16M), Adage Capital Partners GP L.L.C. ($2.06M), Rosalind Advisors Inc. ($1.58M), Woodline Partners LP ($1.15M), Ally Bridge Group NY LLC ($788.71K), Landscape Capital Management L.L.C. ($553.36K), and Rubric Capital Management LP ($537.19K). How much institutional selling is happening at Trevi Therapeutics? Institutional investors have sold a total of 10,306,095 shares in the last 24 months. This volume of shares sold represents approximately $47.88M in transactions. Related Companies LYEL Major Shareholders APLS Major Shareholders OGN Major Shareholders HCM Major Shareholders IBRX Major Shareholders AMRX Major Shareholders XENE Major Shareholders MIRM Major Shareholders ARWR Major Shareholders AAPG Major Shareholders This page (NASDAQ:TRVI) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TRVI Stock Free TRVI Stock Alerts